{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Femoral head fracture",
      "Glycocalyx",
      "Hypoxia-inducible factor",
      "Valinomycin"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33115641",
  "DateCompleted": {
    "Year": "2020",
    "Month": "12",
    "Day": "29"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "12"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "10",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.bj.2020.10.003",
      "S2319-4170(20)30172-4"
    ],
    "Journal": {
      "ISSN": "2320-2890",
      "JournalIssue": {
        "Volume": "43",
        "Issue": "5",
        "PubDate": {
          "Year": "2020",
          "Month": "Oct"
        }
      },
      "Title": "Biomedical journal",
      "ISOAbbreviation": "Biomed J"
    },
    "ArticleTitle": "Don't sugar coat the COVID (only the vasculature).",
    "Pagination": {
      "StartPage": "393",
      "EndPage": "398",
      "MedlinePgn": "393-398"
    },
    "Abstract": {
      "AbstractText": [
        "This issue of the Biomedical Journal acquaints us with the compelling hypothesis that the vascular glycocalyx lies at the intersection of severe COVID-19 risk factors and damages, and the ways used by artificial intelligence to predict interactions between SARS-CoV-2 and human proteins. Furthermore, we explore the antiviral potential of valinomycin and the long list of COVID-19-related clinical trials, and learn how (not) to fix a broken femoral head. Last but not least, we get to enjoy the tale of the cellular oxygen-sensing system as well as the role of the host complement system during Leptospira infection, and learn that SARS-CoV-2 can sometimes come with a pathogenic plus one."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 Chang Gung University. Published by Elsevier B.V. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Copenhagen, BRIC Biotech Research & Innovation Centre, Anders Lund Group, Copenhagen, Denmark. Electronic address: sophia.hafner@bric.ku.dk."
          }
        ],
        "LastName": "H\u00e4fner",
        "ForeName": "Sophia Julia",
        "Initials": "SJ"
      }
    ],
    "PublicationTypeList": [
      "Editorial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Biomed J",
    "NlmUniqueID": "101599820",
    "ISSNLinking": "2319-4170"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Sugars"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Artificial Intelligence"
    },
    {
      "QualifierName": [
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Sugars"
    }
  ]
}